Clinical implementation of a cervical cancer screening program via co-testing at a university hospital.
The Human Papillomavirus (HPV) test is a crucial technology for cervical cancer prevention because it enables programs to identify women with high-risk HPV infection who are at risk of developing cervical cancer. Current U.S. Preventive Services Task Force recommendations include cervical cancer scr...
Main Authors: | Valeria Denninghoff, Felicitas von Petery, Cristóbal Fresno, Mercedes Galarza, Florencia Torres, Alejandra Avagnina, Vanina Fishkel, Hugo Krupitzki, Angel Fiorillo, Fernando Monge |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0278476 |
Similar Items
-
Clinical implementation of a cervical cancer screening program via co-testing at a university hospital
by: Valeria Denninghoff, et al.
Published: (2022-01-01) -
Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening
by: Beatriz Bellosillo, et al.
Published: (2024-03-01) -
Lectins in Cervical Screening
by: Anita WW Lim, et al.
Published: (2020-07-01) -
Costs and benefits of cervical screening IV: valuation by women of the cervical screening programme.
by: Wordsworth, S, et al.
Published: (2001) -
Improving cervical cancer screening
by: The Star,
Published: (2015)